EU

European Urology Oncology

European Urology Oncology is the official journal of the European Association of Urology focused on genitourinary malignancies. It publishes high quality clinical, basic, and translational research with a multidisciplinary approach spanning urology, medical oncology, radiation therapy, imaging, pathology, and basic research. The journal includes original articles, opinion piece editorials, and invited reviews, is published six times a year in electronic format, and uses peer review.

Looking to publish in European Urology Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology, Urology & Nephrology
Impact Factor 9.3
Quartile Q1
Open Access Type Hybrid
eISSN 2588-9311
Invitation Only No
Cost Range USD 4190 APC for all open access articles, excluding taxes; no open access publication fee for subscription articles.

Submission Instructions

European Urology Oncology accepts the following article types. Click on an article type to view submission instructions.

Original Articles

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. Abstract must not exceed 250 words. Abstract must be structured. Abstract must use the headings Background and Objective, Methods, Key Findings and Limitations, and Conclusions and Clinical Implications, and it must end with a patient summary of two or three short sentences in plain English.
Manuscript Original Articles must be no longer than 2750 words including the abstract but excluding references, tables, figures, and legends. Text must be divided into Introduction; Material (Patients) and Methods; Results; Discussion; and Conclusions. Manuscript must include a 'What does the study add?' section of 3 to 4 sentences, and a take home message of two or three sentences not exceeding 40 words must be uploaded as a separate file, and the manuscript must include a declaration of generative AI and AI-assisted technologies in the writing process at the end of the core manuscript before the references if applicable.
References Original Articles must have no more than 40 references. References must follow AMA format. References must be listed in the order cited in the text, with all authors listed for up to six authors and the first three authors followed by et al for more than six authors.
Figures & Tables Tables must be provided as editable Word files.
Reformat to European Urology Oncology using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required for Review Articles. Abstract must be no more than 250 words. Abstract must be structured. Abstract must use the headings Background and Objective, Methods, Key Findings and Limitations, and Conclusions and Clinical Implications, and it must include a patient summary at the end of the abstract consisting of two or three short sentences in plain English.
Manuscript Review Articles must be no longer than 3750 words including the abstract and body, excluding references, tables, figures, and legends. Text must be divided into Introduction, Evidence Acquisition, Evidence Synthesis, and Conclusions. Manuscript must include a 'What does the study add?' section of 3 to 4 sentences, and a take home message of two or three sentences not exceeding 40 words must be uploaded as a separate file, and a Declaration of Generative AI and AI-assisted technologies in the writing process section must be placed at the end of the core manuscript before the references list if applicable.
References Review Articles must have no more than 60 references. References must follow AMA format. References must be listed in the order cited in the text, with all authors listed for references with up to six authors and the first three authors followed by et al for references with more than six authors.
Figures & Tables Review Articles may include a maximum of 6 tables and/or figures. Additional figures and tables beyond 6 must be submitted as supplementary material for online-only publication.
Reformat to European Urology Oncology using Livewrite Premium

Letters To The Editor About A Recent Journal Article

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Text must not exceed 500 words excluding references. Manuscripts must include a Declaration of Generative AI and AI-assisted technologies in the writing process at the end of the core manuscript before the references if such tools were used.
References A maximum of 5 references is allowed. References must follow AMA format. References must be listed in the order cited in the text, with all authors named for works with up to six authors and the first three authors followed by et al for works with more than six authors.
Figures & Tables Figures and tables are not allowed.
Reformat to European Urology Oncology using Livewrite Premium

Research Letters

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Text must not exceed 500 words excluding references, tables, figures, and legends. Research Letters must include a title. A declaration of generative AI and AI-assisted technologies in the writing process must be included at the end of the core manuscript file before the references list if such tools were used.
References No more than 5 references are allowed. References must follow AMA format. References must be listed in the order cited in the text, with all authors listed for up to six authors and the first three authors followed by et al for more than six authors.
Figures & Tables Either 1 table or 1 figure is allowed.
Reformat to European Urology Oncology using Livewrite Premium

Brief Report

Cover Letter Cover Letter requirements are not specified.
Abstract An unstructured abstract is required. Abstract must be no longer than 200 words. Abstract must be unstructured and end with a patient summary of two or three short sentences in plain English.
Manuscript Manuscript text must be limited to 1000 words excluding the abstract, references, and legends. Manuscript must include a title page, abstract, text, references, and as appropriate figure legends, tables, and figures, and it must also include a 'What does the study add?' section of 3 to 4 sentences. Manuscript must include 3 to 10 keywords on the title page, a patient summary at the end of the abstract, a separate take home message of 2 or 3 sentences not exceeding 40 words, and a Declaration of Generative AI and AI-assisted technologies in the writing process section before the references when applicable.
References References are limited to 10. References must follow AMA format. References must be listed in the order cited in the text, with all authors listed for up to six authors and the first three authors followed by et al for more than six authors.
Figures & Tables No more than 2 figures or tables may be included. Tables must be provided as editable Word files.
Reformat to European Urology Oncology using Livewrite Premium

Rapid Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. The abstract must be 100–150 words. The abstract must be unstructured. The abstract must include a patient summary describing how the study would apply to a patient population.
Manuscript The manuscript body must be no more than 1000 words. A take home message of two or three sentences and no more than 40 words must be uploaded as a separate file, and a declaration of generative AI and AI-assisted technologies in the writing process must be included at the end of the core manuscript before the references in a section with that title.
References A maximum of 10 references is allowed. References must use AMA format. References must be listed in the order cited in the text, with all authors listed for up to six authors and the first three authors followed by et al for more than six authors.
Figures & Tables A maximum of 2 tables and/or figures in total is allowed.
Reformat to European Urology Oncology using Livewrite Premium

Fast Track Articles

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required.
Manuscript Manuscript must include a title page, abstract, text, references, and, as appropriate, figure legends, tables, and figures. Manuscript must include 3–10 keywords in alphabetical order on the title page and a declaration of generative AI and AI-assisted technologies in the writing process at the end of the core manuscript before the references if such tools were used.
References References must follow AMA format. References must be listed in the order cited in the text, with all authors listed for works with up to six authors and the first three authors followed by et al for works with more than six authors.
Figures & Tables Tables must be provided as editable Word files.
Reformat to European Urology Oncology using Livewrite Premium

Recent Publications

Diagnostic Accuracy of Liquid-Based Biomarkers for Detecting and Risk Stratifying Upper Tract Urothelial Cancers: A Diagnostic Test Systematic Review by the EAU Guidelines UTUC Panel

Bhavan Prasad Rai, Karthik Rajan, Prabhakar Rajan, Benjamin Pradere, Otakar Capoun, Viktor Soukup, Paolo Gontero, Francesco Soria, Alison Birtle, Eva M. Compérat, Jose-Luis Dominguez-Escrig, Yuhong Yuan, Fredrik Liedberg, Morgan Rouprêt, Thomas Seisen, Jeremy Y. Teoh, Marco Moschini, Paramananthan Mariappan, Shahrokh F. Shariat, Evanguelos Xylinas, Joyce Baard, David D’Andrea, Bas W.G. van Rhijn, Alexandra Masson-Lecomte

10.1016/j.euo.2026.04.011
View Publication

Baseline Frailty, Treatment Intensity, and Clinical Outcomes Among Older Adults with Locally-advanced Prostate Cancer

Agustin Perez-Londono, Jamil Almohtasib, Sumedh Kaul, Aaron Fleishman, Ruslan Korets, Peter Chang, Andrew Wagner, Aria F. Olumi, Marc Garnick, Boris Gershman

10.1016/j.euo.2026.04.012
View Publication

Neoadjuvant Intravesical Therapy for Patients with Non–muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis

Paolo Zaurito, Pietro Scilipoti, Alfonso Santangelo, Alison Birtle, Lydia Makaroff, Eva Compérat, José L. Dominguez-Escrig, Fredrik Liedberg, Paramananthan Mariappan, Alexandra Masson-Leconmte, Jeremy Yuen-Chun Teoh, Benjamin Pradere, Bhavan P. Rai, Bas W.G. van Rhijn, Thomas Seisen, Shahrokh F. Shariat, David D’Andrea, Francesco Soria, Robert Wood, Evanguelos Xylinas, Francesco Montorsi, Alberto Briganti, Paolo Gontero, Marco Moschini

10.1016/j.euo.2026.04.010
View Publication

SBRT for High-risk Localised Prostate Cancer: SHARP and the Limits of Non-randomised Evidence

Peter J. Hoskin, Ananya Choudhury

10.1016/j.euo.2026.04.005
View Publication

Pembrolizumab Plus Lenvatinib in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort E

Marinela Augustin, Brigitte Laguerre, Capucine Baldini, Ahmed H. Zedan, Enrique Gonzalez-Billalabeitia, Peter C. Fong, Ruslan Zukov, Peter Hammerer, Mark Prentice, Neal Shore, Andrea Necchi, Tilman Todenhöfer, Elizabeth R. Kessler, Fatih Kose, Howard Gurney, Begona P. Valderrama, Pengfei Zhu, Kentaro Imai, Yingjie Liu, Ray McDermott

10.1016/j.euo.2026.03.026
View Publication

Frequently asked questions

How long does it take to publish?

3 days from submission to first decision; 24 days from submission to decision after review; 71 days from submission to acceptance.

Reformat to European Urology Oncology using Livewrite Premium

Is a cover letter required?

Cover letters are not mandatory for general submission. For Clinical Trial Protocol submissions, authors should include a cover letter specifying whether the manuscript was invited by the EUO Editorial Board.

Reformat to European Urology Oncology using Livewrite Premium

What are the publication costs?

Open access APC: USD 4190 excluding taxes for all articles. Subscription publication has no open access publication fee.

Reformat to European Urology Oncology using Livewrite Premium

Research Topics

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Bladder and Urothelial Cancer Treatments Renal cell carcinoma treatment Urinary and Genital Oncology Studies Cancer Immunotherapy and Biomarkers Advanced Radiotherapy Techniques Urinary Bladder and Prostate Research Radiopharmaceutical Chemistry and Applications Cancer, Lipids, and Metabolism Esophageal Cancer Research and Treatment Cancer Genomics and Diagnostics Urologic and reproductive health conditions Diverse Scientific and Economic Studies Human auditory perception and evaluation Educational Robotics and Engineering Ferroptosis and cancer prognosis MRI in cancer diagnosis Renal and related cancers Cancer survivorship and care Urological Disorders and Treatments Radiomics and Machine Learning in Medical Imaging PARP inhibition in cancer therapy Multiple and Secondary Primary Cancers Testicular diseases and treatments

Related Journals

LP
Lancet Planetary Health Elsevier BV
AJ
American Journal Of Kidney Diseases Elsevier BV
Ne
Neuro-oncology Oxford University Press
PB
Pharmacology Biochemistry And Behavior Elsevier BV
IJ
International Journal Of Obstetric Anesthesia Elsevier BV
JO
Journal Of Clinical And Translational Endocrinology Elsevier BV